Fig. 2. The inhibitory effects of galangin and myricetin on VEGF secretion.
(A) Galangin inhibited secretion of VEGF by A2780/CP70 and OVCAR-3 cells. (B) Myricetin inhibited secretion of VEGF by A2780/CP70 and OVCAR-3 cells. The human ovarian cancer cell line A2780/CP70 and OVCAR-3 were treated with varying concentrations of galaing and myricetin for 24 hours. Subsequently, the VEGF levels in the supernatant were measured by ELISA. *p < 0.05 as compared to control.